Volitionrx (VNRX) Shares Outstanding (2011 - 2025)

Volitionrx (VNRX) has 15 years of Shares Outstanding data on file, last reported at $125.8 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 30.89% year-over-year to $125.8 million; the trailing twelve-month figure through Dec 2025 stood at $125.8 million (up 30.89% YoY), and the FY2025 full-year result was $125.8 million, up 30.89% from the prior year.
• Shares Outstanding for Q4 2025 stood at $125.8 million, up from $109.6 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $125.8 million in Q4 2025 and bottomed at $52.9 million in Q1 2021.
• The 5-year median for Shares Outstanding is $78.2 million (2023), against an average of $76.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding rose 1.32%; it then surged 45.11% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $53.8 million in 2021, then advanced by 7.63% to $57.9 million in 2022, then soared by 41.51% to $81.9 million in 2023, then rose by 17.34% to $96.1 million in 2024, then jumped by 30.89% to $125.8 million in 2025.
• The last three Shares Outstanding figures came in at $125.8 million (Q4 2025), $109.6 million (Q3 2025), and $104.0 million (Q2 2025), per Business Quant data.

Peer Comparison